 |
|
|
| |
Atorvastatin and Fluvastatin are Associated with Dose-Dependent Reductions in Cirrhosis and HCC Among Patients with HCV: Results from ERCHIVES
|
| |
| |
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Tracey G. Simon MD1,2, Hector Bonilla, MD3, Peng Yan5, Raymond T. Chung, MD1,2, Adeel A. Butt MD, MS4,5,6 1Liver Center, Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Boston MA, 2Harvard Medical School, Boston MA, 3Diablo Infectious Diseases, Castro Valley CA, 4Weill Cornell Medical College, Doha Qatar and New York, NY, 5VA Pittsburgh Healthcare System, Pittsburgh PA, 6Hamad Healthcare Quality Institute and Hamad Medical Corporation, Doha Qatar
|
| |
|
|
|
|
|
